<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2022-21-3-63-71</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-1560</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРАКТИЧЕСКИЕ АСПЕКТЫ ЭПИДЕМИОЛОГИИ И ВАКЦИНОПРОФИЛАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRACTICAL ASPECTS OF EPIDEMIOLOGY AND VACCINE PREVENTION</subject></subj-group></article-categories><title-group><article-title>Вспышка COVID-19 в спортивном клубе: условия возникновения и причины распространения инфекции</article-title><trans-title-group xml:lang="en"><trans-title>COVID-19 Outbreak at Sports Club: Conditions of Occurrence and Causes of the Spread of Infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4812-2165</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голубкова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Golubkova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алла Александровна Голубкова – д. м. н., профессор, ведущий научный сотрудник лаборатории инфекций, связанных с  оказанием медицинской помощи; профессор кафедры эпидемиологии</p><p>111123, Москва, ул. Новогиреевская, д. 3а</p><p>125993, Москва, ул. Баррикадная, д. 2/1, строение 1</p><p>+7 (912) 617-39-85</p></bio><bio xml:lang="en"><p>Alla A. Golubkova − Dr. Sci. (Med.), Professor, leading researcher of the laboratory of infections associated with the provision of medical care; professor of the Department of Epidemiology</p><p>3A, Novogireevskaya str., Moscow, 111123</p><p>2/1 building 1, Barrikadnaya str., Moscow, 125993</p></bio><email xlink:type="simple">allagolubkova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5441-854X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Платонова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Platonova</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Платонова Татьяна Александровна, к. м. н., заведующая эпидемиологическим отделом, врач-эпидемиолог</p><p>620144, г. Екатеринбург, ул. Шейнкмана,д. 113. </p><p>+7 (343) 344-27-67, доб. 1894, +7 (982) 691-88-30</p></bio><bio xml:lang="en"><p>Platonova Tatyana A., Cand. Sci. (Med.), head of the epidemiological Department - epidemiologist</p><p>113, Sheinkmana str., Yekaterinburg, 620144</p><p>+7 (343) 344-27-67, # 1894, +7 (982) 691-88-30</p></bio><email xlink:type="simple">fill.1990@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9749-4611</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Светлана Сергеевна Смирнова – к. м. н., руководитель Урало-Сибирского научно-методического центра по профилактике инфекций, связанных с оказанием медицинской помощи; доцент кафедры эпидемиологии, социальной гигиены и  организации госсанэпидслужбы</p><p>620030, г. Екатеринбург, ул. Летняя, д. 23</p><p>620028, г. Екатеринбург, ул. Репина, д. 3</p><p>+7 (343) 261-99-47 (доб. 106), +7 (908) 917-59-86</p></bio><bio xml:lang="en"><p>Svetlana S. Smirnova − Cand. Sci. (Med.), head of the Ural-Siberian Scientific and Methodological Center for the Prevention of Infections Associated with the Provision of  Medical Assistance; associate Professor of the Department of epidemiology, social hygiene and organization of the state sanitary and epidemiological service</p><p>23, Letnyaya str., Ekaterinburg, 620030</p><p>3, Repin str., Yekaterinburg, 620028</p><p>+7  (343) 261-99-47#106, +7  (908) 917-59-86</p></bio><email xlink:type="simple">smirnova_ss69@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1465-5548</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комиссарова</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Komissarova</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ксения Сергеевна Комиссарова – младший научный сотрудник лаборатории молекулярной вирусологии</p><p>197376, Санкт-Петербург, ул. Профессора Попова, 15/17</p><p>+7 (911) 036-14-63</p></bio><bio xml:lang="en"><p>Ksenia S. Komissarova – junior researcher of laboratory of molecular virology</p><p>15/17, Prof. Popova str., Saint Petersburg</p></bio><email xlink:type="simple">kseniya.sintsova1994@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3273-0660</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Варченко</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Varchenko</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кирилл Вадимович Варченко – ведущий программист отдела этиологии и эпидемиологии</p><p>197376, Санкт-Петербург, ул. Профессора Попова, 15/17</p><p> </p></bio><bio xml:lang="en"><p>Kirill V. Varchenko  – leading programmer of  department of  etiology and epidemiology</p><p>15/17, Prof. Popova str., Saint Petersburg</p></bio><email xlink:type="simple">kirill.varchenko@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «ЦНИИ Эпидемиологии» Роспотребнадзора; ФГБОУ ДПО РМАНПО Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central research Institute of epidemiology of Rospotrebnadzor; Russian Medical Academy of Continuing Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО «Европейский медицинский центр «УГМК-Здоровье»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>European medical center «UMMC-Health»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ЕНИИВИ ФБУН ГНЦ ВБ «Вектор Роспотребнадзора; ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>ERIVI, FBRI SRC VB «Vector», Rospotrebnadzor; Ural state medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ «НИИ гриппа им. А. А. Смородинцева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Smorodintsev Research Institute of Influenza</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>09</day><month>07</month><year>2022</year></pub-date><volume>21</volume><issue>3</issue><fpage>63</fpage><lpage>71</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Голубкова А.А., Платонова Т.А., Смирнова С.С., Комиссарова К.С., Варченко К.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Голубкова А.А., Платонова Т.А., Смирнова С.С., Комиссарова К.С., Варченко К.В.</copyright-holder><copyright-holder xml:lang="en">Golubkova A.A., Platonova T.A., Smirnova S.S., Komissarova K.S., Varchenko K.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/1560">https://www.epidemvac.ru/jour/article/view/1560</self-uri><abstract><p>Актуальность. Новая коронавирусная инфекция (COVID-19), которая возникла в конце 2019 г. в КНР, буквально за несколько месяцев охватила практически все страны мира. Эксплозивный характер распространения вируса SARS-CoV-2 сопровождался формированием крупных эпидемических очагов в организациях различного профиля, в том числе досуговых и спортивных. Цель исследования – на основе углубленного эпидемиологического анализа установить условия и причины распространения SARS-CoV-2 среди членов одного из спортивных клубов. Материалы и методы. Для изучения особенностей распространения вируса SARS-CoV-2 в спортивной организации были использованы ранее разработанные авторами и успешно апробированные на практике «Акт эпидемиологического расследования групповой и вспышечной заболеваемости новой коронавирусной инфекцией (COVID-19) на предприятии/организации/учреждении» и «Индивидуальная карта заболевшего новой коронавирусной инфекцией (COVID-19) на предприятии/организации/учреждении». В процессе эпидемиологического расследования для выявления РНК SARS-CoV-2 в ПЦР было проведено лабораторное обследование участников спортивного клуба (заболевших и контактных) с последующим полногеномным секвенированием выделенных вирусов SARS-CoV-2 на базе лаборатории молекулярной вирусологии ФГБУ «НИИ гриппа им. А. А. Смородинцева», выполняющей данные виды исследований. Результаты и обсуждение. В течение 17 дней среди членов спортивной команды и сотрудников из группы сопровождения (тренерский штаб, медицинский персонал, администраторы) было зарегистрировано 26 лабораторно подтвержденных случаев COVID-19. У большинства заболевших (76,9%) болезнь протекала в форме острой респираторной инфекции легкой степени тяжести, у двух человек (7,7%) – бессимптомно, у четырех (15,4%) – в виде интерстициальной пневмонии. Из клинических проявлений заболевания наиболее частыми были слабость, повышение температуры тела, головная боль, боли в мышцах и суставах, затруднение носового дыхания и серозно-слизистые выделения из носа, боль в горле, кашель, одышка, аносмия и диспепсические проявления в виде диареи, тошноты или рвоты. Возникновение вспышечной заболеваемости было следствием заноса инфекции из команды-соперника на турнире. Ведущими способствовавшими распространению SARS-CoV-2 среди членов спортивного клуба факторами были: допуск на игры и тренировки спортсменов с острыми респираторными инфекциями; продолжительный близкий контакт между игроками во время тренировок и соревнований; нарушения в использовании средств индивидуальной защиты, в соблюдении требований гигиены и антисептики рук и дезинфекционных мероприятиях в помещениях спортивных учреждений; дефекты выполнения регламента обследования команд на SARS-CoV-2 в период проведения турниров. Заключение. Результаты исследования особенностей распространения SARS-CoV-2 в спортивных организациях могут быть использованы при проведении профилактических и противоэпидемических мероприятий в спортивных и досуговых учреждениях.</p></abstract><trans-abstract xml:lang="en"><p>Relevance. The new coronavirus infection (COVID-19), which appeared in late 2019 in China, has spread to almost all countries of the world in just a few months. The explosive nature of its spread was accompanied by the formation of large epidemic foci in organizations of various profiles, including leisure and sports. Aims. To establish the conditions and causes of the spread of SARS-CoV-2 among the members of one of the sports clubs based on an in-depth epidemiological analysis. Materials and methods. To study the features of the spread of the SARS-CoV-2 virus in a sports organization, the following documents were used previously developed by the authors and successfully tested in practice: «Act of epidemiological investigation of group and outbreak morbidity of new coronavirus infection (COVID-19) at an enterprise/organization/institution» and «Individual card of a patient with a new coronavirus infection (COVID-19) at the enterprise / organization/institution». In the process of epidemiological investigation, in order to detect SARS-CoV-2 RNA in PCR, a laboratory examination of sports club participants (sick and contact) was conducted, followed by genome-wide sequencing of isolated SARS-CoV-2 viruses on the basis of the Laboratory of Molecular Virology of the A. A. Smorodintsev Influenza Research Institute, which performs these types of studies. Results. Within 17 days, 26 cases of COVID- 19 were registered among the sports team members and staff from the support group (coaching staff, medical staff, administrators), which was 74.3% of their actual number. The majority of patients (76.9%) had mild acute respiratory infection, two (7.7%) had no symptoms, and four (15.4%) had interstitial pneumonia. Of the clinical manifestations of the disease, the most frequent were weakness, fever, headache, muscle and joint pain, difficulty in nasal breathing and serous-mucous discharge from the nose, sore throat, cough, shortness of breath, anosmia and dyspeptic manifestations in the form of diarrhea, nausea or vomiting. The occurrence of the outbreak was the result of the introduction of infection from the opposing team at the tournament. The leading factors that contributed to the spread of COVID-19 among sports club members were the admission to games and training of athletes with acute respiratory infections, prolonged close contact between players during training and competitions, violations in the use of personal protective equipment, compliance with hygiene and hand antiseptics, disinfection measures in the premises of sports institutions and defects in the implementation of the regulations for the examination of teams for SARS-CoV-2 during tournaments. Conclusion. Based on the results of the study, data were obtained on the features of the spread of SARS-CoV-2 in sports organizations, which can be used in conducting preventive and anti-epidemic measures in sports and leisure institutions.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>вспышечная заболеваемость</kwd><kwd>спортивный клуб</kwd><kwd>причины распространения</kwd><kwd>профилактика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>outbreak incidence</kwd><kwd>sports club</kwd><kwd>causes of spread</kwd><kwd>prevention</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гоми Р., Асгари Н., Хаджихейдари А., Эстеки Р., Бйабанаки Ф., Насиринасаб Ф. Пандемия COVID-19: систематический обзор современных данных. Инфекция и иммунитет. 2020. Т. 10. № 4. С. 655–663.</mixed-citation><mixed-citation xml:lang="en">Ghomi R., Asgari N., Hajiheydari A., Esteki R., Biyabanaki F., Nasirinasab F. The COVID-19 pandemic: a systematic review of the current evidence. Russian Journal of Infection and Immunity. 2020;10(4):655–663 (In Russ.). https://doi.org/10.15789/2220-7619-TCP-1508</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Брико Н. И., Каграманян И. Н., Никифоров В. В. и др. Пандемия COVID-19. Меры борьбы с ее распространением в Российской Федерации. Эпидемиология и Вакцинопрофилактика. 2020;19(2):4–12.</mixed-citation><mixed-citation xml:lang="en">Briko N.I., Kagramanyan I.N., Nikiforov V.V., et al. Pandemic COVID-19. Prevention Measures in the Russian Federation. Epidemiology and Vaccinal Prevention. 2020;19(2):4– 12 (In Russ.). https://doi.org/10.31631/2073-3046-2020-19-2-4-12</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Щелканов М. Ю., Колобухина Л. В., Бургасова О. А. и др. COVID-19: этиология, клиника, лечение. Инфекция и иммунитет. 2020. Т. 10, № 3. С. 421–445.</mixed-citation><mixed-citation xml:lang="en">Shchelkanov M.Yu., Kolobukhina L.V., Burgasova O.A., et al. COVID-19: etiology, clinical picture, treatment. Russian Journal of Infection and Immunity. 2020,10(3):421–445. (In Russ.). doi:10.15789/2220-7619-CEC-1473</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Твердохлебова Т. И., Ковалёв Е. В., Карпущенко Г. В. и др. Социально-экономические аспекты COVID-19 на примере Ростовской области. Инфекционные болезни. 2020. Т. 18. № 4. С. 27–32.</mixed-citation><mixed-citation xml:lang="en">Tverdokhlebova T.I., Kovalev E.V., Karpushchenko H.V., et al. Socioeconomic aspects of COVID-19 on the example of Rostov region. Infectious diseases. 2020;18(4):27–32 (In Russ.). DOI: 10.20953/1729-9225-2020-4-27-32</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Коронавирус. Онлайн-карта распространения коронавирусной инфекции [Электронный ресурс]. Доступно на: https://coronavirus-monitor.ru/ (дата обращения 01.01.2022).</mixed-citation><mixed-citation xml:lang="en">The coronavirus. Online map of the spread of coronavirus infection [Electronic resource] Available at: https://coronavirus-monitor.ru/ (accessed 01.01.2022) (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Агафонова Е. В., Куликов С. Н., Решетникова И. Д. и др. Результаты исследования серопревалентности к SARS-CoV-2 у медицинских работников: возрастные и профессиональные аспекты. Эпидемиология и Вакцинопрофилактика. 2021;20(2):49–57.</mixed-citation><mixed-citation xml:lang="en">Agafonova E.V., Kulikov S.N., Reshetnikova I.D., et al. Seroprevalence study results to SARS-CoV-2 in healthcare workers: age and professional aspects. Epidemiology and Vaccinal Prevention. 2021;20(2):49–57 (In Russ.). https://doi.org/10.31631/2073-3046-2021-20-2-49-57</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Venugopal U., Jilani N., Rabah S., et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. 2021. №102. Р.63–69.</mixed-citation><mixed-citation xml:lang="en">Venugopal U., Jilani N., Rabah S., et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. 2021;102:63–69. doi: 10.1016/j.ijid.2020.10.036.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Alserehi Н.А., Alqunaibet А.М., Al-Tawfiq J.A., et al. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals. Diagnostic Microbiology and Infectious Disease. 2021. Vol. 99, Issue 3, Р.115273.</mixed-citation><mixed-citation xml:lang="en">Alserehi НА, Alqunaibet АМ, Al-Tawfiq JA, et al. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals. Diagnostic Microbiology and Infectious Disease. 2021;99(3):115273. https://doi.org/10.1016/j.diagmicrobio.2020.115273</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Schwierzeck V., Correa-Martinez C.L., Schneider K.N., et al. SARS-CoV-2 in the Employees of a Large University Hospital. Dtsch Arztebl Int. 2020. Vol. 117. N. 9. Р344–345.</mixed-citation><mixed-citation xml:lang="en">Schwierzeck V., Correa-Martinez C.L., Schneider K.N., et al. SARS-CoV-2 in the Employees of a Large University Hospital. Dtsch Arztebl Int. 2020;117(9):344–345. doi: 10.3238/arztebl.2020.0344.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chou R., Dana T., Buckley D.I. et al. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review. Ann Intern Med. 2020. Vol. 173. N.2:120–136.</mixed-citation><mixed-citation xml:lang="en">Chou R., Dana T., Buckley D.I., et al. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review. Ann Intern Med. 2020;173(2):120– 136. doi: 10.7326/M20-1632.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X., Liu W., Zhao J., et al. Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China. Journal of Hospital Infection. 2020. Vol. 105. N3. P. 399–403.</mixed-citation><mixed-citation xml:lang="en">Wang X., Liu W., Zhao J. et al. Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China. Journal of Hospital Infection. 2020;105(3):399–403. DOI: 10.1016/j.jhin.2020.04.019</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Calo F., Russo A., Camaioni C., et al. Burden, risk assessment, surveillance and management of SARS-CoV-2 infection in health workers: a scoping review. Infect Dis Poverty. 2020. Vol. 9. N1. P.139.</mixed-citation><mixed-citation xml:lang="en">Calo F., Russo A., Camaioni C., et al. Burden, risk assessment, surveillance and management of SARS-CoV-2 infection in health workers: a scoping review. Infect Dis Poverty. 2020;9(1):139. doi: 10.1186/s40249-020-00756-6</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hughes M.M., Groenewold M.R., Lessem S.E., et al. Update: Characteristics of Health Care Personnel with COVID-19 - United States, February 12-July 16, 2020. MMWR Morb Mortal Wkly Rep. 2020. Vol. 69. N.38. P.1364–1368.</mixed-citation><mixed-citation xml:lang="en">Hughes M.M., Groenewold M.R., Lessem S.E., et al. Update: Characteristics of Health Care Personnel with COVID-19 - United States, February 12-July 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1364–1368. doi: 10.15585/mmwr.mm6938a3.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Buonafine C.P., Paiatto B.N.M., Leal F.B., et al. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. BMC Infect Dis. 2020. Vol. 20. N.1. Р. 917.</mixed-citation><mixed-citation xml:lang="en">Buonafine C.P., Paiatto B.N.M., Leal F.B., et al. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. BMC Infect Dis. 2020;20(1):917. doi: 10.1186/s12879-020-05662-8</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Treibel T.A., Manisty C., Burton M., et al. COVID-19: PCR screening of asymptomatic health-care workers at London hospital. Lancet. 2020. Vol. 395. N 10237. P. 1608–1610.</mixed-citation><mixed-citation xml:lang="en">Treibel T.A., Manisty C., Burton M., et al. COVID-19: PCR screening of asymptomatic health-care workers at London hospital. Lancet. 2020;395(10237):1608–1610. doi: 10.1016/S0140-6736(20)31100-4</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hunter E., Price D.A., Murphy E., et al. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020. Vol. 395. N 10234. P. 77–78.</mixed-citation><mixed-citation xml:lang="en">Hunter E., Price D.A., Murphy E., et al. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020;395(10234):e77–e78. doi: 10.1016/S0140-6736(20)30970-3</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen L.H., Drew D.A., Joshi A.D., et al. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. Lancet Public Health. 2020. N 5. P. 475–483.</mixed-citation><mixed-citation xml:lang="en">Nguyen L.H., Drew D.A., Joshi A.D., et al. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. Lancet Public Health. 2020;5:475–483. doi: 10.1101/2020.04.29.20084111</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Shields A., Faustini S.E., Perez-Toledo M., et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020. N 75. P. 1089–1094.</mixed-citation><mixed-citation xml:lang="en">Shields A., Faustini S.E., Perez-Toledo M., et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study Thorax 2020;75:1089–1094. DOI:10.1136/thoraxjnl-2020-215414</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lucey M., Macori G., Mullane N., et al. Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks. Clin Infect Dis. 2020. ciaa1433. doi: 10.1093/cid/ciaa1433.</mixed-citation><mixed-citation xml:lang="en">Lucey M., Macori G., Mullane N., et al. Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks. Clin Infect Dis. 2020.1433. doi: 10.1093/cid/ciaa1433.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Paltansing S., Sikkema R.S., de Man S.J., et al. Transmission of SARS-CoV-2 among healthcare workers and patients in a teaching hospital in the Netherlands confirmed by whole-genome sequencing. J Hosp Infect. 2021. N 110. P.178–183.</mixed-citation><mixed-citation xml:lang="en">Paltansing S., Sikkema R.S., de Man S.J., et al. Transmission of SARS-CoV-2 among healthcare workers and patients in a teaching hospital in the Netherlands confirmed by whole-genome sequencing. J Hosp Infect. 2021;110:178–183. doi: 10.1016/j.jhin.2021.02.005</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Borges V., Isidro J., Macedo F., et al. Nosocomial Outbreak of SARS-CoV-2 in a «Non-COVID-19» Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission. Viruses. 2021. Vol. 13. N 4. Р. 604. doi: 10.3390/v13040604.</mixed-citation><mixed-citation xml:lang="en">Borges V., Isidro J., Macedo F., et al. Nosocomial Outbreak of SARS-CoV-2 in a «Non-COVID-19» Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission. Viruses. 2021;13(4):604. doi: 10.3390/v13040604</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lu J., Gu J., Li K., et al. COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020. Emerg Infect Dis. 2020. Vol. 26. N. 7. Р. 1628–1631. doi: 10.3201/eid2607.200764.</mixed-citation><mixed-citation xml:lang="en">Lu J., Gu J., Li K., et al. COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020. Emerg Infect Dis. 2020;26(7):1628–1631. doi: 10.3201/eid2607.200764</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y., Qian H., Hang J., et al. Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant. Build Environ. 2021. 196:107788.</mixed-citation><mixed-citation xml:lang="en">Li Y., Qian H., Hang J., et al. Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant. Build Environ. 2021;196:107788. doi: 10.1016/j.build-env.2021.107788</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon K.S., Park J.I., Park Y.J., Jung D.M., Ryu K.W., Lee J.H. Evidence of Long-Distance Droplet Transmission of SARS-CoV-2 by Direct Air Flow in a Restaurant in Korea. J Korean Med Sci. 2020. Vol. 35. N. 46. Р.415.</mixed-citation><mixed-citation xml:lang="en">Kwon K.S., Park J.I., Park Y.J., et al. Evidence of Long-Distance Droplet Transmission of SARS-CoV-2 by Direct Air Flow in a Restaurant in Korea. J Korean Med Sci. 2020;35(46):e415. doi: 10.3346/jkms.2020.35.e415</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ortiz-Prado E., Henriquez-Trujillo A.R., Rivera-Olivero I.A., et al. UDLA-COVID-19 team. High prevalence of SARS-CoV-2 infection among food delivery riders. A case study from Quito, Ecuador. Sci Total Environ. 2021. N. 770. Р. 145225. doi: 10.1016/j.scitotenv.2021.145225.</mixed-citation><mixed-citation xml:lang="en">Ortiz-Prado E., Henriquez-Trujillo A.R., Rivera-Olivero I.A., et al. UDLA-COVID-19 team. High prevalence of SARS-CoV-2 infection among food delivery riders. A case study from Quito, Ecuador. Sci Total Environ. 2021;770:145225. doi: 10.1016/j.scitotenv.2021.145225</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Morawska L., Tang J.W., Bahnfleth W., et al. How can airborne transmission of COVID-19 indoors be minimised? Environ Int. 2020. N. 142. Р. 105832. doi: 10.1016/j.en-vint.2020.105832.</mixed-citation><mixed-citation xml:lang="en">Morawska L., Tang J.W., Bahnfleth W., et al. How can airborne transmission of COVID-19 indoors be minimised? Environ Int. 2020;142:105832. doi: 10.1016/j.en-vint.2020.105832</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y., Ning Z., Chen Y., et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 2020; Vol. 7813. N. 582. Р. 557–560. doi: 10.1038/s41586-020-2271-3.</mixed-citation><mixed-citation xml:lang="en">Liu Y., Ning Z., Chen Y., et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 2020;582(7813):557–560. doi: 10.1038/s41586-020-2271-3</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Toresdahl B.G., Asif I.M. Coronavirus Disease 2019 (COVID-19): Considerations for the Competitive Athlete. Sports Health. 2020. Vol. 12. N. 3. Р.221–224.</mixed-citation><mixed-citation xml:lang="en">Toresdahl B.G., Asif I.M. Coronavirus Disease 2019 (COVID-19): Considerations for the Competitive Athlete. Sports Health. 2020;12(3):221–224. doi: 10.1177/1941738120918876</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dale A.P., Scott S.E., Sunenshine R. COVID-19 Outbreaks Associated With Youth Club Sports: Maricopa County, Arizona, September-November 2020. Am J Public Health. 2022. Vol. 112. N 2. P. 216–219. doi: 10.2105/AJPH.2021.306579.</mixed-citation><mixed-citation xml:lang="en">Dale A.P., Scott S.E., Sunenshine R. COVID-19 Outbreaks Associated With Youth Club Sports: Maricopa County, Arizona, September-November 2020. Am J Public Health. 2022;112(2):216–219. doi: 10.2105/AJPH.2021.306579</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Atherstone C., Siegel M., Schmitt-Matzen E., et al. SARS-CoV-2 Transmission Associated with High School Wrestling Tournaments - Florida, December 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021. Vol. 70. N 4. P. 141–143. doi: 10.15585/mmwr.mm7004e4.</mixed-citation><mixed-citation xml:lang="en">Atherstone C., Siegel M., Schmitt-Matzen E., et al. SARS-CoV-2 Transmission Associated with High School Wrestling Tournaments - Florida, December 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021;70(4):141–143. doi: 10.15585/mmwr.mm7004e4</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Gualano B., Brito G.M., Pinto A.J., et al. High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil. Br J Sports Med. 2021. P. 104431. doi: 10.1136/bjsports-2021-104431.</mixed-citation><mixed-citation xml:lang="en">Gualano B., Brito G.M., Pinto A.J., et al. High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil. Br J Sports Med. 2021:bjsports-2021-104431. doi: 10.1136/bjsports-2021-104431</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Watson A.M., Haraldsdottir K., Biese K., et al. The Association of COVID-19 Incidence with Sport and Face Mask Use in United States High School Athletes. J Athl Train. 2021. doi: 10.4085/1062-6050-281-21.</mixed-citation><mixed-citation xml:lang="en">Watson A.M., Haraldsdottir K., Biese K., et al. The Association of COVID-19 Incidence with Sport and Face Mask Use in United States High School Athletes. J Athl Train. 2021. doi: 10.4085/1062-6050-281-21</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Alessi-LaRosa S., Hughes M.R. Jr, Alessi A.G. SARS-CoV-2 Positivity in a Combat Sports Bubble. Neurology. 2022. Vol. 98 (12 Suppl 2). S17. doi: 10.1212/01.wnl.0000801896.48894.7e.</mixed-citation><mixed-citation xml:lang="en">Alessi-LaRosa S., Hughes M.R. Jr, Alessi A.G. SARS-CoV-2 Positivity in a Combat Sports Bubble. Neurology. 2022;98(12 Suppl 2):S17. doi: 10.1212/01.wnl.0000801896.48894.7e</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Krug A., Appleby R., Pizzini R., Høeg T.B. Youth ice hockey COVID-19 protocols and prevention of sport-related transmission. Br J Sports Med. 2022. Vol. 56. N 1. P. 29–34. doi: 10.1136/bjsports-2021-104363.</mixed-citation><mixed-citation xml:lang="en">Krug A., Appleby R., Pizzini R., Høeg T.B. Youth ice hockey COVID-19 protocols and prevention of sport-related transmission. Br J Sports Med. 202;56(1):29–34. doi: 10.1136/bjsports-2021-104363</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
